|
8 May 2008
|
Intervet/Schering-Plough Animal Health appoints Executive Team
Boxmeer, May 08, 2008 – Schering-Plough appointed the Executive Team members of the company’s global animal health unit: Intervet / Schering- Plough Animal Health. These appointments define the major ...
|
|
29 Apr 2008
|
Intervet/Schering-Plough Animal Health outlines strength of the combination
First batch of bluetongue Bovilis BTV8 vaccine released to supply Northern European countriesBoxmeer, April 29, 2008 – Intervet/Schering-Plough Animal Health released the first batch of Bovilis BTV8 vaccine ...
|
|
17 Mar 2008
|
Prof. Dr. George Gettinby wins Dieter Luetticken Award
Boxmeer, March 17, 2008 – Intervet’s Dieter Lϋtticken Award has been granted to Prof. Dr. George Gettinby from the University of Strathclyde, Scotland, United Kingdom. Gettinby’s innovative statistical ...
|
|
29 Feb 2008
|
Intervet will supply French government with a minimum quantity of 27 million doses of Bluetongue vaccine
Angers, February 29, 2008 – Today, Intervet received an official order of the Department for Agriculture and Fishery, France, to supply inactivated vaccine against Bluetongue, serotype 8.Intervet is working ...
|
|
27 Feb 2008
|
Intervet takes the lead in veterinary endocrinology at NAVC
Orlando, February 27, 2008 – As part of its global program to encourage continuing education and research in the field of veterinary internal medicine, Intervet International, a part of Schering-Plough, ...
|
|
19 Jan 2008
|
Schering-Plough & Intervet together for better care
Orlando, FL, U.S.A., January 19, 2008 –Throughout its history, Schering-Plough has focused on discovering and developing innovative new therapies in the human prescription, animal health and consumer ...
|
|
16 Jan 2008
|
Intervet has developed Bluetongue vaccine
Boxmeer, January 16, 2008 – Animal health company Intervet International bv, part of Schering-Plough Corporation, has developed a vaccine against Bluetongue serotype 8, for sheep and cattle. The vaccine ...
|
|
19 Nov 2007
|
Akzo Nobel completes OBS sale
Intervet herewith publishes a press release by Akzo NobelAkzo Nobel completes OBS sale Amsterdam, the Netherlands, November 19, 2007 – Akzo Nobel N.V. has today completed the sale of Organon BioSciences ...
|
|
19 Nov 2007
|
Schering-Plough Completes Acquisition of Organon BioSciences
Intervet herewith publishes a press release by Schering-PloughSchering-Plough Completes Acquisition of Organon BioSciencesCombination Expands Human Health Business, Creates a Global Leader in Animal Health ...
|
|
10 Oct 2007
|
Intervet wins award at ECVIM-CA congress
Intervet wins an award for a scientific poster presentation on its new product Zitac® Vet during the annual congress of the ECVIM-CA. This year’s ECVIM-CA (European College of Veterinary Internal ...
|
|
24 Sep 2007
|
Lipoxen and Intervet Announce a Collaboration Agreement to Develop Sustained-Release Insulin
Intervet herewith publishes a press release by Lipoxen Lipoxen PLC (“Lipoxen” or “the Company”) Lipoxen and Intervet, a leading Animal Health company, Announce a Collaboration Agreement to Develop ...
|
|
24 Aug 2007
|
Prof. Mark Stevens honored with Dieter Lütticken Award
British scientist awarded for excellent contribution to the principle of 3Rs for the development and production of veterinary medicinal productsBoxmeer, August 24, 2007 – At the '6th World Congress on ...
|
|
29 Jun 2007
|
Intervet opens formulation and filling unit at its international competence center for Foot and Mouth Disease
Today, Intervet, largest vaccine producer world wide, opens a new formulation and filling unit at the Foot and Mouth Disease (FMD) vaccine factory in Cologne, Germany. With this factory Intervet substantially ...
|
|
22 Jun 2007
|
Intervet Dieter Luetticken Award
Intervet’s award to reduce the number of animals used in testing for development and production of animal veterinary medicinesIntervet offers the Dieter Lütticken award to promote scientists or life science ...
|
|
11 May 2007
|
Intervet's bird flu vaccine receives EU license
Intervet, a leading animal health company, received approval for its bird flu (avian influenza) vaccine Nobilis® Influenza H7N1. As a result, Europe now has a licensed vaccine to protect birds against ...
|
|
3 May 2007
|
Dieter Luetticken Award Winner
The annual Dieter Lütticken Award, has been granted to Dr Mark Stevens from the Institute of Animal Health, United Kingdom for his commitment to advancing the 3R concept – reducing, refining or replacing ...
|
|
12 Mar 2007
|
Akzo Nobel announces Intended Sale of Organon Biosciences to Schering-Plough for EUR 11 billion
Akzo Nobel is pleased to announce that on March 11, 2007, it received an offer for the purchase of its wholly owned subsidiary Organon BioSciences N.V. (OBS) from Schering-Plough for EUR 11 billion in ...
|
|
26 Feb 2007
|
Akzo Nobel confirms IPO timing of Organon Biosciences
For more information check the Akzo Nobel website: http://www.akzonobel.com/com/News/News.htm?itemid=f14e3b3a-9dd9-4819-b181-701fcb6ae520
|
|
15 Feb 2007
|
Akzo Nobel Annual Results 2006: Record year
Operational highlights • Revenues up 6% – growth in all segments • Record net income of EUR 1.15 billion – up 20% • Operational results up 14% • Incidentals positive contribution ...
|
|
29 Jan 2007
|
Intervet opens new production facility for vaccines
Intervet, the world’s largest producer of vaccines for animals, will open a production facility for vaccines in Boxmeer, the Netherlands, today. This will strengthen Boxmeer’s position as Intervet’s largest ...
|
|
25 Jan 2007
|
Akzo Nobel reconfirms listing of Organon Biosciences
Akzo Nobel has previously announced its intention to separate its Pharma business, preferably through a listing of approximately 20 to 30 percent of Organon BioSciences shares on Euronext in Amsterdam ...
|
About Intervet
